Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy HUTCHMED DRC stock

Learn how to easily invest in HUTCHMED DRC stock.

HUTCHMED DRC is a drug manufacturers-specialty & generic business based in the US. HUTCHMED DRC shares (HCM) are listed on the NASDAQ and all prices are listed in US Dollars. HUTCHMED DRC employs 2,110 staff and has a trailing 12-month revenue of around $400.8 million.

How to buy shares in HUTCHMED DRC

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – HCM – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.


Use our graph to track the performance of HCM stocks over time.

HUTCHMED DRC shares at a glance

Information last updated 2022-09-26.
Latest market close$9.05
52-week range$8.37 - $37.00
50-day moving average $12.66
200-day moving average $18.54
Wall St. target price$29.31
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-1.23

Buy HUTCHMED DRC shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 8 of 8
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Stocks, ETFs, Cryptocurrency
8%-12% of your deposit
when you sign up and deposit at least $50. T&Cs apply.
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, TN, and HI.
Stocks, ETFs, Cryptocurrency
Receive a free stock slice worth between $3–$300
when you sign up for an account and deposit at least $20.
Commission-free trading in stocks and ETFs with a social networking twist.
Stocks, Options, ETFs, Cryptocurrency
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$125 - $625
when you open and fund an account with $25,000 - $250,000+
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 3% interest on uninvested cash in your account with Robinhood Gold.
Ally Invest Self-Directed Trading
Stocks, Bonds, Options, Mutual funds, ETFs
when you deposit or transfer $10,000–$24,900
500+ commission-free ETFs, some of the industry's lowest fees plus a cash bonus up to $3,000.
Stocks, Options, ETFs
Customize your trade platform or build your own Deep tools, charts and screens Analyzers to help you study before you trade

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy HUTCHMED DRC stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

HUTCHMED DRC price performance over time

Historical closes compared with the close of $9.05 from 2022-09-27

1 week (2022-09-21) -4.74%
1 month (2022-08-26) -27.07%
3 months (2022-06-28) -31.95%
6 months (2022-03-28) -51.29%
1 year (2021-09-28) -75.11%
2 years (2020-09-28) -72.07%
3 years (2019-09-27) 17.97
5 years (2017-09-28) 27.24

HUTCHMED DRC financials

Revenue TTM $400.8 million
Gross profit TTM $-201,192,000
Return on assets TTM -19.32%
Return on equity TTM -24.72%
Profit margin -63.65%
Book value $4.74
Market capitalisation $1.6 billion

TTM: trailing 12 months

HUTCHMED DRC share dividends

We're not expecting HUTCHMED DRC to pay a dividend over the next 12 months.

Have HUTCHMED DRC's shares ever split?

HUTCHMED DRC's shares were split on 29 May 2019.

HUTCHMED DRC share price volatility

Over the last 12 months, HUTCHMED DRC's shares have ranged in value from as little as $8.37 up to $37. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while HUTCHMED DRC's is 0.4991. This would suggest that HUTCHMED DRC's shares are less volatile than average (for this exchange).


HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and renal cell carcinoma, colorectal cancer (CRC), and gastric cancer (GC); and Fruquintinib, an inhibitor for CRC, breast cancer, GC, endometrial cancer (EMC), NSCLC, hepatocellular carcinoma, and gastrointestinal and solid tumors. It also develops Surufatinib, an inhibitor for neuroendocrine tumors (NET), pancreatic NET, non-pancreatic NET, biliary tract cancer, sarcoma, neuroendocrine neoplasm, esophageal cancer, small cell lung cancer, GC, thyroid cancer, EMC, NSCLC, and solid tumors; HMPL-523, a spleen tyrosine kinase inhibitor for hematological cancers and certain chronic immune diseases; and HMPL-689 for isoform PI3Kd (phosphoinositide 3'-kinase delta). In addition, it develops Tazemetostat, an inhibitor of EZH2 for the treatment of certain epithelioid sarcoma and follicular lymphoma patients; HMPL-306, an inhibitor for hematological malignancies, gliomas, and solid tumors; HMPL-760, an Bruton's tyrosine kinase inhibitor; HMPL-453, an inhibitor for intrahepatic cholangiocarcinoma; HMPL-295 for solid tumors; HMPL-653 for metastatic solid tumors and tenosynovial giant cell tumors; and Epitinib (HMPL-813) and Theliatinib (HMPL-309) inhibitors. It has collaboration agreements with AstraZeneca AB (publ), Lilly (Shanghai) Management Company Limited, BeiGene, Inmagene Biopharmaceuticals Co. Ltd.

Frequently asked questions

What percentage of HUTCHMED DRC is owned by insiders or institutions?
Currently 0.413% of HUTCHMED DRC shares are held by insiders and 29.987% by institutions.
How many people work for HUTCHMED DRC?
Latest data suggests 2,110 work at HUTCHMED DRC.
When does the fiscal year end for HUTCHMED DRC?
HUTCHMED DRC's fiscal year ends in December.
Where is HUTCHMED DRC based?
HUTCHMED DRC's address is: Cheung Kong Center, Central, Hong Kong
What is HUTCHMED DRC's ISIN number?
HUTCHMED DRC's international securities identification number is: US44842L1035
What is HUTCHMED DRC's CUSIP number?
HUTCHMED DRC's Committee on Uniform Securities Identification Procedures number is: 44842L103

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site